Annual Total Debt
$134.50 M
-$103.07 M-43.39%
December 31, 2022
Summary
- As of March 3, 2025, SRNE annual total debt is $134.50 million, with the most recent change of -$103.07 million (-43.39%) on December 31, 2022.
- During the last 3 years, SRNE annual total debt has fallen by -$156.28 million (-53.74%).
- SRNE annual total debt is now -53.74% below its all-time high of $290.78 million, reached on December 31, 2019.
Performance
SRNE Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$207.60 M
+$38.05 M+22.44%
June 30, 2023
Summary
- As of March 3, 2025, SRNE quarterly total debt is $207.60 million, with the most recent change of +$38.05 million (+22.44%) on June 30, 2023.
- Over the past year, SRNE quarterly total debt has increased by +$38.05 million (+22.44%).
- SRNE quarterly total debt is now -34.44% below its all-time high of $316.64 million, reached on September 30, 2019.
Performance
SRNE Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
SRNE Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.4% | +22.4% |
| 3 y3 years | -53.7% | +22.4% |
| 5 y5 years | +2481.2% | +22.4% |
SRNE Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.4% | at low | -16.6% | +54.3% |
| 5 y | 5-year | -53.7% | at low | -28.6% | +54.3% |
| alltime | all time | -53.7% | -100.0% | -34.4% | -100.0% |
Sorrento Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $207.60 M(+22.4%) |
| Mar 2023 | - | $169.55 M(+26.1%) |
| Dec 2022 | $134.50 M(-43.4%) | $134.50 M(-20.0%) |
| Sep 2022 | - | $168.21 M(-17.8%) |
| Jun 2022 | - | $204.61 M(-17.8%) |
| Mar 2022 | - | $248.88 M(+4.8%) |
| Dec 2021 | $237.58 M(+40.3%) | $237.58 M(+17.3%) |
| Sep 2021 | - | $202.56 M(+23.0%) |
| Jun 2021 | - | $164.74 M(+6.4%) |
| Mar 2021 | - | $154.76 M(-8.6%) |
| Dec 2020 | $169.39 M(-41.7%) | $169.39 M(-24.0%) |
| Sep 2020 | - | $222.91 M(+0.9%) |
| Jun 2020 | - | $220.84 M(-13.4%) |
| Mar 2020 | - | $255.01 M(-12.3%) |
| Dec 2019 | $290.78 M(+24.6%) | $290.78 M(-8.2%) |
| Sep 2019 | - | $316.64 M(+2.0%) |
| Jun 2019 | - | $310.29 M(+7.6%) |
| Mar 2019 | - | $288.50 M(+23.7%) |
| Dec 2018 | $233.29 M(+4376.8%) | $233.29 M(+34.3%) |
| Sep 2018 | - | $173.77 M(+881.0%) |
| Jun 2018 | - | $17.71 M(+149.7%) |
| Mar 2018 | - | $7.09 M(+36.2%) |
| Dec 2017 | $5.21 M(-89.0%) | $5.21 M(-80.7%) |
| Sep 2017 | - | $26.98 M(+1.7%) |
| Jun 2017 | - | $26.54 M(+1.8%) |
| Mar 2017 | - | $26.08 M(-44.9%) |
| Dec 2016 | $47.32 M(+412.7%) | $47.32 M(+738.0%) |
| Sep 2016 | - | $5.65 M(-17.8%) |
| Jun 2016 | - | $6.87 M(-14.8%) |
| Mar 2016 | - | $8.06 M(-12.6%) |
| Dec 2015 | $9.23 M(-24.0%) | $9.23 M(-11.0%) |
| Sep 2015 | - | $10.37 M(-9.7%) |
| Jun 2015 | - | $11.48 M(-5.8%) |
| Mar 2015 | - | $12.19 M(+0.4%) |
| Dec 2014 | $12.15 M(+152.8%) | $12.15 M(+0.4%) |
| Sep 2014 | - | $12.10 M(+0.4%) |
| Jun 2014 | - | $12.05 M(+0.4%) |
| Mar 2014 | - | $12.00 M(+149.8%) |
| Dec 2013 | $4.80 M | $4.80 M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $4.79 M(+478.4%) |
| Jun 2013 | - | $827.30 K(-5.5%) |
| Mar 2013 | - | $875.90 K(>+9900.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2005 | - | $9500.00(0.0%) |
| Jun 2005 | - | $9500.00(0.0%) |
| Mar 2005 | - | $9500.00(0.0%) |
| Dec 2004 | $9500.00(0.0%) | $9500.00(0.0%) |
| Sep 2004 | - | $9500.00(0.0%) |
| Jun 2004 | - | $9500.00(0.0%) |
| Mar 2004 | - | $9500.00 |
| Dec 2003 | $9500.00 | - |
FAQ
- What is Sorrento Therapeutics annual total debt?
- What is the all time high annual total debt for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual total debt year-on-year change?
- What is Sorrento Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly total debt year-on-year change?
What is Sorrento Therapeutics annual total debt?
The current annual total debt of SRNE is $134.50 M
What is the all time high annual total debt for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual total debt is $290.78 M
What is Sorrento Therapeutics annual total debt year-on-year change?
Over the past year, SRNE annual total debt has changed by -$103.07 M (-43.39%)
What is Sorrento Therapeutics quarterly total debt?
The current quarterly total debt of SRNE is $207.60 M
What is the all time high quarterly total debt for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly total debt is $316.64 M
What is Sorrento Therapeutics quarterly total debt year-on-year change?
Over the past year, SRNE quarterly total debt has changed by +$38.05 M (+22.44%)